Philadelphia Chromosome{t(9:22)} (bcr-abl) Quantitative, Blood
Guaranteed Safe Checkout
Philadelphia Chromosome{t(9:22)} (bcr-abl) Quantitative, Blood
Monitor and diagnose Philadelphia Chromosome t(9;22) (BCR-ABL)–positive leukemia with the Philadelphia Chromosome {t(9;22)} (BCR-ABL) Quantitative, Blood Test at Lucid Medical Diagnostics in Hyderabad. This advanced molecular test uses quantitative PCR to measure BCR-ABL fusion gene transcripts, supporting the diagnosis and ongoing monitoring of Chronic Myeloid Leukemia (CML) and selected cases of Acute Lymphoblastic Leukemia (ALL). The test helps assess treatment response, monitor minimal residual disease (MRD), and guide targeted therapy decisions. Using advanced molecular diagnostic technology and stringent quality standards, Lucid Medical Diagnostics delivers accurate, reliable, and timely results to support optimal patient care and clinical outcomes.
Home Sample Collection Available
Get Reports
